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Introduction
CANDLE syndrome is an exceptional inflammatory condi-
tion starting within the first months of life, and comprising
elevated fever, panniculitis with lipoatrophy, purplish and
swollen eyelids, arthralgia, and developmental retardation.
Most patients carry homozygous mutations in the PSMB8
gene that impair the assembly of the immunoproteasome
(iP) and lead to interferon g deregulation. Since now,
39 published case reports under various acronyms have
shown clinical and genetic heterogeneity, suggestive of
various mechanisms underlying this very severe condition.
We present two new cases enlarging the spectrum of
CANDLE phenotype
Case Report
1: A Sicilian girl, born at term in 1986 with microcephaly,
skin panniculitic rash since 2 weeks, hepatosplenomegaly,
microcytic anemia, leucopenia with extreme lymphopenia,
myelemia, thrombopenia, elevated ESR, liver enzymes and
ANA, first suspected with neonatal lupus. She developped
recurrent otitis media and pneumonitis. Following years,
recurrent fever, severe growth and mental retardation
(cerebral calcification, seizures), purplish swollen eyelids,
rashes mimicking dermatomyositis, joint contracture,
severe lipoatrophy, diabetes requiring insulin therapy, dys-
lipidemia and finally severe hypertension and giant aortic
aneurysm that killed her at the age of 16y. Proteasome
exons PMSB1-10, PSME1-3, PSMA1-6 were screened and
did not reveal any mutation. No other biologic material is
available for IFNy investigation. 2: A French girl, born in
2009, onset at 2 months, hepatosplenomegaly, seizures,
panniculitis, fever with peaks, swollen eyelids and some-
times hands and feet, joint contracture and lipoatrophy
increasing with time. She also has marked leucopenia,
microcytic anemia and elevated liver enzymes. Extensive
work up to rule out other condition not contributive.
PMSB8 gene analyses are ongoing
Discussion
Case 1 could be considered as an extreme severity phe-
notype of CANDLE, as the developmental retardation
was intriguing (final height 87cm), immunodeficiency
and autoimmunity were both present with also important
metabolic disturbances, finally she died early at 18y. Case
2 shares many features of CANDLE, even the skin biopsy
was not typical (immature white cells not retrieved).
She may have mild developmental retardation. These
2 patients confirm that other causes outside the protea-




1Paediatric Rheumatology, CeReMAI, Bicetre Hospital, University of Paris Sud,
Le Kremlin Bicetre, France. 2Human Genetics, Nagasaki University Hospital,
Nagasaki, Japan. 3Respirology, Neurology, Rheumatology, Kurume University
School of Medicine, Kurume, Japan. 4Pediatrics, CH de Hyères, Hyeres,
France. 5Dermatology, CHU de Bordeaux, Bordeaux, France. 6Pediatric
Rheumatology, CHU de Bordeaux, Bordeaux, France.
Published: 8 November 2013
References
1. Kanazawa N, et al: Procced Nat Ac Sci USA 2011, 108:14914-9.
2. Liu y, et al: Arthritis Rheum 2012, 64(3):895-907.
doi:10.1186/1546-0096-11-S1-A116
Cite this article as: Kone-Paut et al.: P02-009 - Candle syndrome:
expanding spectrum. Pediatric Rheumatology 2013 11(Suppl 1):A116.
1Paediatric Rheumatology, CeReMAI, Bicetre Hospital, University of Paris Sud,
Le Kremlin Bicetre, France
Full list of author information is available at the end of the article
Kone-Paut et al. Pediatric Rheumatology 2013, 11(Suppl 1):A116
http://www.ped-rheum.com/content/11/S1/A116
© 2013 Kone-Paut et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
